Cll Leukemia Life Expectancy
Cll Leukemia Life Expectancy: The new study have found that approximately 50 percent of CLL (Chronic lymphocytic leukemia) patients who are diagnosed in the early stage of the disease live for more than 12 years. However about 50 percent of CLL patients with advanced stage CLL leukemia life expectancy is may be less than 2 years. There are many factors that can influence the CLL leukemia life expectancy of patient include: The extent of lymphcytosis in the bone marrow, Development of chronic lymphocytic leukemia related complications, The CLL patient’s response to initial treatment, Age: 65 years or older CLL patients have a shorter 5 year life expectancy than patient with younger than age 65.
Cll usually progresses slowly and is characterized by the accumulation of lymphocytes, or special white blood cells, in the bone marrow. The elimination of chronic lymphocytic leukemia to an extremely low level may extend CLL leukemia life expectancy and improve overall survival rate. The new study finds that about 85% of patients who had no detectable chronic lymphocytic leukemia cells after receiving alemtuzumab had more than 5 year CLL leukemia life expectancy.
Cll usually progresses slowly and is characterized by the accumulation of lymphocytes, or special white blood cells, in the bone marrow. The elimination of chronic lymphocytic leukemia to an extremely low level may extend CLL leukemia life expectancy and improve overall survival rate. The new study finds that about 85% of patients who had no detectable chronic lymphocytic leukemia cells after receiving alemtuzumab had more than 5 year CLL leukemia life expectancy.
Copyright 2011 AcuteLymphoblasticLeukemia.Org
AcuteLymphoblasticLeukemia.Org
Custom Search
Custom Search
cll leukemia life expectancy
Cll Luekemia Life Expectancy of each Rai stage
Early signs and detection of leukemia
Leukemia is a cancer of white blood cells, so the values of white blood cells, red blood cells and platelets can provide the detection of leukemia by bone marrow biopsy. If the number of abnormal white blood cells is high, the CLL symptoms will occur. For chronic leukemia form is sometime monitored for some time before treatment to ensure maximum effectiveness of therapy. Knowing what to expect about your cll leukemia prognosis is very important aspects of coping with the disease. Rai and Binet Stageing is very useful in CLL to predict CLL leukemia life expectancy, prognosis and risk.
Rai stage 0 (low risk): CLL patients have lymphocytosis without enlarged lymph nodes and low risk, defined by lymphocyte count are more than 15,000/mm3 and more than 40% lymphocytes in bone marrow. Average Cll leukemia life expectancy and survival rate is about 11 -12 years
Rai stage I (intermediate risk): CLL patients have lymphocytosis and enlarged lymphadenopathy (enlarged lymph nodes) and intermediate risk (stage 0 with enlarged nodes (lymphadenopathy)) Average Cll leukemia expectancy and survival rate is about 11 years
Rai stage II (intermediate risk): CLL patients have lymphocytosis and enlarged spleen (splenomegaly) or enlarge liver (hepatomegaly and may be without or with lymphadenopathy (enlarged lymph node) and this stage is intermediate risk. Average Cll leukemia life expectancy and survival rate is about 7-8 years
Rai stage III (high risk): low red blood cell count, hemoglobin less than 11 g/dl and anemia, Rai stage III is high risk. Average Cll leukemia life expectancy and survival rate is about 5.3 years.
Rai stage IV (high risk): stage0-III anemia and thrombocytopenia with platelets less than 100,000/mcl, Rai stage IV is high risk. Average Cll leukemia life expectancy and survival rate is about 7 years.
Some Cll patients live for more than 10 years with no need for treatment. The aim of therapy has been to maintain the best quality of life and treat only when Cll patient pain from their symptoms.
Leukemia is a cancer of white blood cells, so the values of white blood cells, red blood cells and platelets can provide the detection of leukemia by bone marrow biopsy. If the number of abnormal white blood cells is high, the CLL symptoms will occur. For chronic leukemia form is sometime monitored for some time before treatment to ensure maximum effectiveness of therapy. Knowing what to expect about your cll leukemia prognosis is very important aspects of coping with the disease. Rai and Binet Stageing is very useful in CLL to predict CLL leukemia life expectancy, prognosis and risk.
Rai stage 0 (low risk): CLL patients have lymphocytosis without enlarged lymph nodes and low risk, defined by lymphocyte count are more than 15,000/mm3 and more than 40% lymphocytes in bone marrow. Average Cll leukemia life expectancy and survival rate is about 11 -12 years
Rai stage I (intermediate risk): CLL patients have lymphocytosis and enlarged lymphadenopathy (enlarged lymph nodes) and intermediate risk (stage 0 with enlarged nodes (lymphadenopathy)) Average Cll leukemia expectancy and survival rate is about 11 years
Rai stage II (intermediate risk): CLL patients have lymphocytosis and enlarged spleen (splenomegaly) or enlarge liver (hepatomegaly and may be without or with lymphadenopathy (enlarged lymph node) and this stage is intermediate risk. Average Cll leukemia life expectancy and survival rate is about 7-8 years
Rai stage III (high risk): low red blood cell count, hemoglobin less than 11 g/dl and anemia, Rai stage III is high risk. Average Cll leukemia life expectancy and survival rate is about 5.3 years.
Rai stage IV (high risk): stage0-III anemia and thrombocytopenia with platelets less than 100,000/mcl, Rai stage IV is high risk. Average Cll leukemia life expectancy and survival rate is about 7 years.
Some Cll patients live for more than 10 years with no need for treatment. The aim of therapy has been to maintain the best quality of life and treat only when Cll patient pain from their symptoms.
immune system
Cll leukemia life expectancy related tags and keywords
test, stem, health, lymphocytic leukemia/small lymphocytic lymphoma, white blood cell count, rai and binet staging, bone marrow transplant, there is no, small lymphocytic lymphoma, can be, blood test, they are, stem cell, marrow transplant, staging system, this disease, cells are, immune system